DalsnaFinance › Analyst accuracy › Truist Securities › DXCM target
BTIG raises DexCom stock price target to $90 on strong Q2 results
Truist Securities also increased its price target for DexCom to $93 from $87, while keeping a Buy rating.
A fact about what Truist Securities published, as reported by Investing.com, not a recommendation from Dalsna Finance; Truist Securities is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.